Download The Findit App

Share Your Posts On These Major Social Networks

Instatag Your Posts to Instagram Facebook + Twitter

Right Now

Aikido Pharma researches and develops treatment prostate cancer and has secured an early investment in Convergent Therapeutics, Inc. Convergent Therapeutics, Inc. is a startup pharmaceutical company focused on developing next generation radiopharmaceutical therapy for prostate cancer and other applications. Its proprietary technology involves peptide receptor radionuclide therapy (“PRRT”) developed under the direction of Dr. Neil Bander, Professor of Urologic Oncology at Weill Cornell Medicine. For more information, visit us online or call us at 212-745-1373.

More Posts

Load More wait


Aikido Pharma

Get Directions

Aikido Pharma

  • One Rockefeller Plaza
    New York, New York 10020
    United States
  • (212) 745-1373